Mircera and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Mircera (methoxy polyethylene glycol-epoetin beta), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Amlodipine, and have Nephrogenic anaemia.

The phase IV clinical study analyzes which people have Joint pain when taking Mircera. It is created by eHealthMe based on reports of 10,311 people who have side effects when taking Mircera from the FDA, and is updated regularly.

What is Mircera?

Mircera has active ingredients of methoxy polyethylene glycol-epoetin beta. eHealthMe is studying from 10,321 Mircera users. Check the latest studies of Mircera.

What is Joint pain?

Joint pain is found to be associated with 3,330 drugs and 5,207 conditions by eHealthMe. Check the latest studies of Joint pain.

On Jul, 20, 2026

10,311 people reported to have side effects when taking Mircera.
Among them, 36 people (0.35%) have Joint pain.

Among these 36 people:

How long have people been on Mircera when they have Joint pain? *

What is the gender of people who have Joint pain when taking Mircera? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Joint pain when taking Mircera? *

What are other drugs people take besides Mircera? *

What are other side effects people have besides Joint pain? *

Headache (pain in head): 7 people, 19.44%
Drug Hypersensitivity: 7 people, 19.44%
Dyspnea (difficult or laboured breathing): 6 people, 16.67%
High Blood Pressure: 5 people, 13.89%
Back Pain: 4 people, 11.11%
Muscle Aches (muscle pain): 4 people, 11.11%
Diarrhea: 4 people, 11.11%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 8.33%
Rashes (redness): 3 people, 8.33%
Pain In Extremity: 3 people, 8.33%

What are the existing conditions these people have? *

Nephrogenic Anaemia (anaemia due to kidney disease): 8 people, 22.22%
Anaemia (lack of blood): 4 people, 11.11%
Chronic Kidney Disease: 3 people, 8.33%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 3 people, 8.33%
Diabetes: 3 people, 8.33%
High Blood Pressure: 3 people, 8.33%
Gastric Ulcer (stomach ulcer): 3 people, 8.33%
Haemoglobin Decreased: 2 people, 5.56%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 5.56%
Back Pain: 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Mircera and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mircera:

Mircera (10,321 reports)

Joint pain treatments and more:

Joint pain (542,934 reports)

How severe was Joint pain and when was it recovered:

Joint pain in Mircera

Expand to all the drugs that have ingredients of methoxy polyethylene glycol-epoetin beta:

Joint pain and drugs with ingredients of methoxy polyethylene glycol-epoetin beta

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mircera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,330 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,207 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methoxy polyethylene glycol-epoetin beta (the active ingredients of Mircera) and Mircera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.